SLNO Insider Trading

Insider Ownership Percentage: 12.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $139,065,642.37

Soleno Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Soleno Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$265ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50M$0$50MTotal Insider BuyingTotal Insider Selling

Soleno Therapeutics Share Price & Price History

Current Price: $67.23
Price Change: Price Increase of +4.36 (6.93%)
As of 04/11/2025 05:00 PM ET

This chart shows the closing price history over time for SLNO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$67.23Closing price on 04/11/25:

SEC Filings (Institutional Ownership Changes) for Soleno Therapeutics (NASDAQ:SLNO)

97.42% of Soleno Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SLNO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$358kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1B$0$1BTotal InflowsTotal Outflows
Soleno Therapeutics logo
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Read More on Soleno Therapeutics

Today's Range

Now: $67.23
Low: $62.11
High: $67.37

50 Day Range

MA: $53.20
Low: $43.68
High: $73.67

52 Week Range

Now: $67.23
Low: $36.61
High: $74.00

Volume

985,354 shs

Average Volume

707,660 shs

Market Capitalization

$3.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Soleno Therapeutics?

Soleno Therapeutics' top insider shareholders include:
  1. Vivo Opportunity, Llc (Major Shareholder)
  2. Perceptive Advisors Llc (Major Shareholder)
  3. Bhatnagar Anish (CEO)
  4. James H Mackaness (CFO)
  5. Kristen Yen (Insider)
  6. Patricia C Hirano (Insider)
  7. Michael F Huang (VP)
  8. Matthew Pauls (Director)
Learn More about top insider investors at Soleno Therapeutics.

Who are the major institutional investors of Soleno Therapeutics?

Soleno Therapeutics' top institutional investors include:
  1. Rhumbline Advisers — 0.08%
  2. GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Soleno Therapeutics stock.

Which institutional investors are buying Soleno Therapeutics stock?

During the last quarter, SLNO stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Rhumbline Advisers